Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Perlmutter's Eikon raises $351m in major financing round
Pharmaphorum
Wednesday, February 26, 2025 - 9:58am
tags:
Eikon Therapeutics, Roger Perlmutter, funding, cancer
Merck expects Keytruda to face HHS price setting in 2026
MSN/Reuters
Tuesday, February 25, 2025 - 10:45pm
tags:
Merck, Keytruda, HHS, Inflation Reduction Act, drug pricing
Sterotherapeutics begins Phase II trial for ST-002 targeting Cushing’s Syndrome
Clinical Trials Arena
Tuesday, February 25, 2025 - 10:43pm
tags:
Sterotherapeutics, clinical trials, ST-002, Cushing's syndrome
Zantac Lawsuit: Illinois Jury Rules in Favor of Boehringer Ingelheim
Lawyer Monthly
Tuesday, February 25, 2025 - 10:41pm
tags:
Boehringer Ingelheim, Zantac, Illinois, prostate cancer, legal
Organovo’s FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company
Yahoo Finance
Tuesday, February 25, 2025 - 10:38pm
tags:
Organovo, Eli Lilly, FXR agonists, IBD
Drug compounders sue FDA over declaration ending Wegovy shortage
BioPharma Dive
Tuesday, February 25, 2025 - 10:36pm
tags:
drug compounding, Wegovy, FDA, Hims & Hers Health
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
CNBC
Tuesday, February 25, 2025 - 11:14am
tags:
Eli Lilly, Zepbound, weight loss, LillyDirect
PepGen reports positive initial data from Phase I DM1 therapy trial
Clinical Trials Arena
Tuesday, February 25, 2025 - 11:07am
tags:
PepGen, clinical trials, myotonic dystrophy, PGN-EDODM1
J&J takes Samsung Bioepis to court over claims Korean company breached Stelara biosim settlement
Fierce Pharma
Tuesday, February 25, 2025 - 11:00am
tags:
JNJ, Samsung Bioepis, Korea, legal, Stelara, biosimilars
Alabama pharmacists to stage walkout over PBM bill
Beckers Hospital Review
Tuesday, February 25, 2025 - 10:56am
tags:
Alabama, pharmacists, PBMs
Medicare spending on diabetes drugs surged in 5 years
Axios
Tuesday, February 25, 2025 - 10:53am
tags:
Medicare, diabetes, GLP-1 agonists
Lava, smoldering from dropping lead asset, lays off 30% of staff to save cash
Fierce Biotech
Tuesday, February 25, 2025 - 10:52am
tags:
Lava Therapeutics, blood cancer, LAVA-1266, layoffs
Repare unveils scale of layoffs with 75% of staff and chief medical officer heading for exit
Fierce Biotech
Tuesday, February 25, 2025 - 10:49am
tags:
Repare Therapeutics, layoffs
Incentivizing rare disease R&D is getting tougher, but revamped policies could turn the tide
Pharma Voice
Tuesday, February 25, 2025 - 10:47am
tags:
R&D, Rare Diseases, artificial intelligence
FDA brings back some fired device office staff
BioPharma Dive
Tuesday, February 25, 2025 - 10:45am
tags:
FDA, Medtech, devices, HHS
Pharma's AI is missing the "Why”
Pharmaphorum
Tuesday, February 25, 2025 - 10:43am
tags:
artificial intelligence, clinical trials, drug discovery
“Digital genocide”: BMJ post alleges patient data deletion amid DEI purge
Clinical Trials Arena
Tuesday, February 25, 2025 - 10:42am
tags:
BMJ, diversity, Donald Trump
In letter to RFK Jr., Democrats flag threats to drug review process from FDA firings
Fierce Pharma
Monday, February 24, 2025 - 5:07pm
tags:
FDA, drug reviews, HHS, Robert F Kennedy Jr.
Regeneron's gene therapy study shows improved hearing in children with congenital deafness
Contemporary Pediatrics
Monday, February 24, 2025 - 5:05pm
tags:
Regeneron, gene therapy, DB-OTO, genetic hearing loss, genetic deafness
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million
CNBC
Monday, February 24, 2025 - 4:58pm
tags:
23andMe, Anne Wojcicki

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.